2024 |
BridgeBio Pharma Inc
|
Lead Independent Director and Chairman of Pharmace |
- |
- |
2024 |
Maze Therapeutics Inc.
|
Chairman of the Board |
- |
- |
2023 |
BridgeBio Pharma Inc
|
Lead Independent Director and Chairman of Pharmace |
1.1 M |
12.1 % |
2022 |
BridgeBio Pharma Inc
|
Lead Independent Director and Chairman of Pharmace |
992.6 K |
-65.4 % |
2022 |
Pliant Therapeutics Inc
|
Lead Independent Director and Chairman of Pharmace |
19.5 K |
-93.0 % |
2022 |
Pliant Therapeutics Inc
|
Independent Director |
- |
- |
2021 |
BridgeBio Pharma Inc
|
Lead Director and Chairman of Pharmaceuticals |
2.9 M |
- |
2021 |
Pliant Therapeutics Inc
|
Independent Director |
278.4 K |
11.2 % |
2020 |
Pliant Therapeutics Inc
|
Independent Director |
250.4 K |
946.7 % |
2020 |
BridgeBio Pharma Inc
|
Lead Director and Chairman of Pharmaceuticals |
- |
- |
2019 |
Pliant Therapeutics Inc
|
Independent Director |
23.9 K |
- |
2019 |
BridgeBio Pharma Inc
|
Chairman of Pharmaceuticals and Lead Director |
- |
- |
2018 |
BridgeBio Pharma Inc
|
Chairman of Pharmaceuticals and Director |
- |
- |
2011 |
Geron Corp.
|
- |
80.1 K |
-42.2 % |
2011 |
Geron Corp.
|
Director |
- |
- |
2010 |
Geron Corp.
|
Director |
138.6 K |
-39.1 % |
2009 |
Geron Corp.
|
Director |
227.7 K |
110.8 % |
2008 |
Geron Corp.
|
Director |
108.0 K |
-69.3 % |
2008 |
Cytokinetics Inc
|
Director |
55.5 K |
-42.3 % |
2007 |
Geron Corp.
|
Director |
351.6 K |
102.5 % |
2007 |
Cytokinetics Inc
|
Director |
96.1 K |
3.1 % |
2006 |
Geron Corp.
|
Director |
173.6 K |
- |
2006 |
Cytokinetics Inc
|
Director |
93.3 K |
- |
2005 |
Geron Corp.
|
Director |
- |
- |
2005 |
Cytokinetics Inc
|
Director |
- |
- |
2004 |
Geron Corp.
|
Director |
- |
- |
2004 |
Cytokinetics Inc
|
Director |
- |
- |
2003 |
Cytokinetics Inc
|
Director |
- |
- |